Related Experiment Video
Updated: Dec 26, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Astaxanthin Protects Ochratoxin A-Induced Oxidative Stress and Apoptosis in the Heart via the Nrf2 Pathway
Gengyuan Cui1, Lin Li1,2, Weixiang Xu1
1Key Laboratory of Zoonosis of Liaoning Province, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
Abstract:
This study assessed the protective mechanism of astaxanthin (ASX) against ochratoxin A- (OTA-) induced cardiac injury in mice. Four groups of mice were established: control group (0.1 mL olive oil + 0.1 mL NaHCO2), OTA group (0.1 mL OTA 5 mg/kg body weight), ASX group (0.1 mL ASX 100 mg/kg body weight), and ASX + OTA group (0.1 mL ASX 100 mg/kg body weight, 2 h later, 0.1 mL OTA 5 mg/kg body weight). The test period lasted for 27 days (7 days of dosing, 2 days of rest). Electrocardiogram, body weight, heart weight, tissue pathology, oxidative markers (malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH)), biochemical markers (creatine kinase (CK), creatine kinase isoenzyme (CK-MB), and lactate dehydrogenase (LDH)), electron microscopy, TUNEL, and Western blot tests were used to examine the effects of OTA on myocardial injury and ASX detoxification. The results showed that OTA exposure significantly decreased both body weight and heart weight. OTA induced a decrease in heart rate in mice and decreased tissue concentrations of SOD, CAT, and GSH, while increasing serum concentrations of cardiac enzymes (CK, CK-MB, and LDH) and tissue MDA. ASX improved heart rate, cardiac enzymes, and antioxidant levels in mice. The results of tissue pathology and TUNEL assay showed that ASX protects against OTA-induced myocardial injury. In addition, Western blot results showed that the OTA group upregulated Keap1, Bax, Caspase3, and Caspase9, while it downregulated Nrf2, HO-1, and Bcl-2 protein expression. ASX played a protective role by changing the expression of Keap1, Nrf2, HO-1, Bax, Bcl-2, Caspase3, and Caspase9 proteins. These results indicate that the protective mechanism of ASX on the myocardium works through the Keap1-Nrf2 signaling pathway and mitochondria-mediated apoptosis pathway. This study provides a molecular rationale for the mechanism underlying OTA-induced myocardial injury and the protective effect of ASX on the myocardium.
Insights
Astaxanthin (ASX) protects against ochratoxin A (OTA)-induced cardiac injury by modulating oxidative stress and apoptosis. ASX treatment improved cardiac function and antioxidant levels, demonstrating its cardioprotective effects against OTA toxicity.
Area of Science:
- Toxicology
- Cardiovascular Biology
- Nutraceutical Research
Background:
- Ochratoxin A (OTA) is a nephrotoxic and carcinogenic mycotoxin that can cause cardiac injury.
- Astaxanthin (ASX) is a potent antioxidant carotenoid with potential therapeutic benefits.
Purpose of the Study:
- To investigate the protective mechanism of astaxanthin (ASX) against ochratoxin A (OTA)-induced cardiac injury in mice.
- To elucidate the molecular pathways involved in OTA-induced myocardial damage and ASX's protective effects.
Main Methods:
- Mice were divided into control, OTA, ASX, and ASX + OTA groups.
- Evaluated cardiac function via electrocardiogram, body/heart weight, and tissue pathology.
- Assessed oxidative stress markers (MDA, SOD, CAT, GSH), cardiac enzymes (CK, CK-MB, LDH), and apoptosis (TUNEL assay).
- Utilized electron microscopy and Western blot to analyze protein expression related to the Keap1-Nrf2 and apoptosis pathways.
Main Results:
- OTA exposure significantly impaired cardiac function, reduced body and heart weight, and induced oxidative stress and apoptosis.
- ASX administration ameliorated OTA-induced cardiac injury, improving heart rate, antioxidant status, and reducing cardiac enzyme levels.
- ASX treatment reversed OTA-induced changes in protein expression, including the Keap1-Nrf2 pathway and apoptosis-related proteins (Bax, Bcl-2, Caspase3, Caspase9).
Conclusions:
- Astaxanthin exerts significant cardioprotective effects against ochratoxin A-induced myocardial injury.
- The protective mechanism involves the modulation of the Keap1-Nrf2 signaling pathway and inhibition of mitochondria-mediated apoptosis.
- These findings highlight the therapeutic potential of astaxanthin in mitigating mycotoxin-induced cardiac damage.
More Related Videos
Related Concept Videos
Radical Autoxidation
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Intrinsic Apoptotic Pathway

